Ad
related to: drug-resistant tuberculosis
Search results
Millions could soon have access to lifesaving tuberculosis drug following online uproar
ABC News via Yahoo News· 10 months agoIn a move welcomed by advocates, a treatment for multi-drug resistant tuberculosis could soon become...
Levofloxacin could be a cheap solution to drug-resistant tuberculosis, studies say
Euronews via Yahoo News· 6 months agoAn antibiotic, levofloxacin, has shown promising results in curbing the emergence of a particularly...
Tuberculosis Vaccine: In the United States and Around the World
Verywell Health via Yahoo News· 1 year agoThere are several reasons it’s not available in the United StatesMedically reviewed by Ronald...
Johnson and Johnson shares licence for tuberculosis drug after novelist’s viral campaign
The Independent via Yahoo News· 10 months agoPharmaceutical giant Johnson & Johnson announced on Thursday that a Swiss nonprofit will distribute...
Tuberculosis Could Be the Next Global Health Crisis. Is the World Ready?
Time via Yahoo News· 8 months agoThe United Nations General Assembly's high-level meeting on the fight against tuberculosis TB is...
AI can help predict whether a patient will respond to specific tuberculosis treatments, paving way...
The Conversation via Yahoo News· 2 months agoPeople have been battling tuberculosis for thousands of years, and drug-resistant strains are on the...
What Is Tuberculosis?
Health via Yahoo News· 7 months agoTuberculosis (TB) is a curable, contagious bacterial disease that primarily affects the lungs. According to the World Health Organization, it is the...
How an Innovative Deal Will Give Millions Access to Cheaper Tuberculosis Drugs
Time via Yahoo News· 10 months agoWhy a new deal between Johnson & Johnson and the non-profit Global Drug Facility means that the...
J&J, India's Lupin cut prices for tuberculosis drug in lower-income countries
Reuters via Yahoo Finance· 9 months agoThe United Nations-backed Stop TB Partnership said J&J's new price of $130 and Lupin's price of $194...
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India, Makes Way For Domestic Generic...
Benzinga via Yahoo Finance· 1 year agoThe Indian Patent Office rejected Johnson and Johnson's (NYSE: JNJ) application to extend its patent...